272 related articles for article (PubMed ID: 10147046)
1. Impact of consumer fees on drug utilisation.
Smith DG; Kirking DM
Pharmacoeconomics; 1992 Oct; 2(4):335-42. PubMed ID: 10147046
[TBL] [Abstract][Full Text] [Related]
2. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
3. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
Saleh SS; Weller W; Hannan E
J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
[TBL] [Abstract][Full Text] [Related]
4. AMCP Guide to Pharmaceutical Payment Methods.
AMCP Task Force on Drug Payment Methodologies
J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of cost-containment strategies in third party programmes in the US (part I).
Reeder CE; Lingle EW; Schulz RM; Mauch RP; Nightengale BS; Pedersen CA; Watrous ML; Zetzl SE
Pharmacoeconomics; 1993 Aug; 4(2):92-103. PubMed ID: 10146971
[TBL] [Abstract][Full Text] [Related]
6. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence.
Lexchin J; Grootendorst P
Int J Health Serv; 2004; 34(1):101-22. PubMed ID: 15088676
[TBL] [Abstract][Full Text] [Related]
7. Controlling prescription drug expenditures: a report of success.
Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA
Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
[TBL] [Abstract][Full Text] [Related]
8. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
[TBL] [Abstract][Full Text] [Related]
9. Can a pharmacist reduce annual costs for Medicare Part D enrollees?
Alston G; Hanrahan C
Consult Pharm; 2011 Mar; 26(3):182-9. PubMed ID: 21402518
[TBL] [Abstract][Full Text] [Related]
10. What Determines How Much Your Patient Pays for Their Medication in the United States?
Novack GD
Am J Ophthalmol; 2016 Jul; 167():48-51. PubMed ID: 27131775
[TBL] [Abstract][Full Text] [Related]
11. The pharmaceutical market and prescription drugs in the Federal Republic of Germany: cross-national comparisons.
Schicke RK
Int J Health Serv; 1973; 3(2):223-36. PubMed ID: 4197751
[No Abstract] [Full Text] [Related]
12. Patient charges and the utilisation of NHS prescription medicines: some estimates using a cointegration procedure.
Hughes D; McGuire A
Health Econ; 1995; 4(3):213-20. PubMed ID: 7550771
[TBL] [Abstract][Full Text] [Related]
13. The pharmaceutical industry's responsibilities in the prescription process.
Tidball P
Can Pharm J; 1981 May; 114(5):177-9. PubMed ID: 10251274
[No Abstract] [Full Text] [Related]
14. When patients cannot afford their medications.
Tseng CW
Am Fam Physician; 2004 Aug; 70(3):605-6, 608. PubMed ID: 15317446
[No Abstract] [Full Text] [Related]
15. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
Rudholm N
Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
[TBL] [Abstract][Full Text] [Related]
16. Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugs.
Cahn LJ
Manag Care; 2010 Nov; 19(11):21-7. PubMed ID: 21141372
[No Abstract] [Full Text] [Related]
17. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members.
Johnson RE; Goodman MJ; Hornbrook MC; Eldredge MB
Health Serv Res; 1997 Apr; 32(1):103-22. PubMed ID: 9108807
[TBL] [Abstract][Full Text] [Related]
18. Attitudes of the public to medical care: part 6. Pharmaceutical benefits.
Dixon CW; Dodge JS; Emery GM; Salmond GC; Spears GF
N Z Med J; 1975 Jul; 82(544):45-8. PubMed ID: 809735
[TBL] [Abstract][Full Text] [Related]
19. Drug economics and the elderly: prescriptions for change.
Lipton HL
Bus Health; 1988 Mar; 5(5):8-11. PubMed ID: 10312402
[No Abstract] [Full Text] [Related]
20. Statistical comparison of consumer drug expenditures and discretionary purchases to assess drug affordability.
Lee JA; McKercher PL
Clin Ther; 2002 Jun; 24(6):1003-16; discussion 1002. PubMed ID: 12117076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
